AC
BIIB icon

AlphaCore Capital’s Biogen BIIB Stock Holding History

AlphaCore Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Buy
2,010
+678
+51% +$130K 0.01% 755
2026
Q1 		$244K Sell
1,332
-1,222
-48% -$225K 0.01% 767
2025
Q4 		$450K Buy
2,554
+25
+1% +$4.08K 0.01% 644
2025
Q3 		$354K Buy
2,529
+1,883
+291% +$255K 0.01% 545
2025
Q2 		$81.1K Buy
+646
New +$80.5K ﹤0.01% 741

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaCore Capital's BIIB Position: Q2 2026 in Review

AlphaCore Capital increased its Biogen (BIIB) stake by 51% in Q2 2026, buying an estimated $130K and bringing the position to 2,010 shares worth $434K. The position accounts for 0.01% of the portfolio, ranked #755.

AlphaCore Capital first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. The position peaked at $450K in Q4 2025. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • AlphaCore Capital held 2,010 shares of Biogen worth $434K as of Q2 2026.
  • AlphaCore Capital bought 678 Biogen shares in Q2 2026, an estimated $130K.
  • Biogen made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #755 holding.
  • AlphaCore Capital first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
  • AlphaCore Capital's Biogen position peaked at $450K in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.